4,777 Cigna Group $CI Shares Sold by Crossmark Global Holdings Inc.

Key Points

• Crossmark Global Holdings reduced its Cigna stake by 4.4% in the third quarter, selling 4,777 shares and retaining 103,338 shares valued at approximately $28.1 million. Institutional investors own 86.99% of Cigna’s stock.
• Cigna exceeded quarterly expectations, reporting adjusted earnings of $7.78 per share and revenue of $71.56 billion, up 6.7% year over year. The company maintained fiscal 2026 guidance of roughly $30.45 in EPS.
• Analyst sentiment remains favorable, with 15 Buy ratings and eight Holds producing a “Moderate Buy” consensus and an average price target of $338.24, above the reported share price of $304.74.

Crossmark Global Holdings Inc. lessened its stake in Cigna Group (NYSE:CI - Free Report) by 4.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 103,338 shares of the health services provider's stock after selling 4,777 shares during the quarter. Crossmark Global Holdings Inc.'s holdings in Cigna Group were worth $28,090,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of CI. Evercore Wealth Management LLC boosted its position in shares of Cigna Group by 2.8% during the 1st quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider's stock valued at $347,000 after acquiring an additional 35 shares during the last quarter. Independence Bank of Kentucky boosted its position in Cigna Group by 2.6% during the second quarter. Independence Bank of Kentucky now owns 1,483 shares of the health services provider's stock valued at $409,000 after buying an additional 37 shares during the period. West Family Investments Inc. lifted its stake in shares of Cigna Group by 4.2% in the 2nd quarter. West Family Investments Inc. now owns 919 shares of the health services provider's stock valued at $253,000 after acquiring an additional 37 shares during the last quarter. WPG Advisers LLC lifted its stake in shares of Cigna Group by 24.5% in the 1st quarter. WPG Advisers LLC now owns 203 shares of the health services provider's stock valued at $54,000 after acquiring an additional 40 shares during the last quarter. Finally, Maripau Wealth Management LLC boosted its holdings in Cigna Group by 4.0% during the 1st quarter. Maripau Wealth Management LLC now owns 1,074 shares of the health services provider's stock valued at $287,000 after acquiring an additional 41 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Everett Neville sold 617 shares of the company's stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider owned 27,256 shares of the company's stock, valued at $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 22,730 shares of company stock valued at $6,293,359. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Price Performance

CI opened at $304.74 on Thursday. The stock has a fifty day simple moving average of $280.49 and a two-hundred day simple moving average of $282.73. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The company has a market cap of $80.53 billion, a price-to-earnings ratio of 9.74, a price-to-earnings-growth ratio of 1.03 and a beta of 0.29. Cigna Group has a 12-month low of $239.51 and a 12-month high of $311.34.

Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $71.56 billion for the quarter, compared to analysts' expectations of $70.14 billion. During the same quarter in the previous year, the business posted $7.20 EPS. The company's quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts predict that Cigna Group will post 30.50 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Guggenheim raised their target price on shares of Cigna Group from $338.00 to $361.00 and gave the stock a "buy" rating in a report on Friday, July 31st. Barclays increased their target price on shares of Cigna Group from $304.00 to $310.00 and gave the stock an "equal weight" rating in a report on Friday, July 31st. Sanford C. Bernstein restated an "outperform" rating on shares of Cigna Group in a report on Friday, October 2nd. Wall Street Zen raised Cigna Group from a "hold" rating to a "buy" rating in a research report on Saturday, September 26th. Finally, Raymond James Financial cut Cigna Group from a "strong-buy" rating to an "outperform" rating and dropped their price objective for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $338.24.

Cigna Group Profile

The Cigna Group NYSE: CI is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.